Therapeutic effect of probiotic agents on ulcerative colitis: A systematic review

Chinese Journal of Gastroenterology

Volumn 17, Issue 4, 2012, Pages 221-225

  Chen, Ruihong ^a   Li, Yuanfa ^a   Yang, Xin ^b   Xia, Bing ^b  

^a First People's Hospital of Xiantao   (China)

^b ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Colitis, ulcerative; Probiotic agents; Systems analysis; Therapy

Indexed keywords

AMINOSALICYLIC ACID; GLUCOCORTICOID; PLACEBO; PROBIOTIC AGENT;

ARTICLE; COCHRANE LIBRARY; DRUG EFFECT; EMBASE; HUMAN; MEDLINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT RESPONSE; ULCERATIVE COLITIS;

EID: 84861778600     PISSN: 10087125     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1008-7125.2012.06.007     Document Type: Article

References (22)

1. Loftus E V Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences[J]. Gastroenterology, 2004, 126 (6): 1504-1517.
2. Goh K, Xiao S D. Inflammatory bowel disease: a survey of the epidemiology in Asia[J]. J Dig Dis, 2009, 10 (1): 1-6.
3. Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults [J]. Gut, 2011, 60 (5): 571-607.
4. 2007, 12 (1): 488-495.
5. Herías M V, Koninkx J F, Vos J G, et al. Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice[J]. Int J Food Microbiol, 2005, 103 (2): 143-155.
6. Bibiloni R, Fedorak R N, Tannock G W, et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis[J]. Am J Gastroenterol, 2005, 100 (7): 1539-1546.
7. Huynh H Q, deBruyn J, Guan L, et al. Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study[J]. Inflamm Bowel Dis, 2009, 15 (5): 760-768.
8. Adam B, Liebregts T, Holtmann G. Maintaining remission of ulcerative colitis with the probiotic Escherichia Coli Nissle 1917 is as effective as with standard mesalazine (Article in German) [J]. Z Gastroenterol, 2006, 44 (3): 267-269.
9. Straus S E. EVIDENCE-BASED MEDICINE: How to Practice and Teach EBM[M]. 2006: 127.
10. Ishikawa H, Akedo I, Umesaki Y, et al. Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis[J]. J Am Coll Nutr, 2003, 22 (1): 56-63.
11. Kato K, Mizuno S, Umesaki Y, et al. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis [J]. Aliment Pharmacol Ther, 2004, 20 (10): 1133-1141.
12. Furrie E, Macfarlane S, Kennedy A, et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial [J]. Gut, 2005, 54 (2): 242-249.
13. Zocco M A, dal Verme L Z, Cremonini F, et al. Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis[J]. Aliment Pharmacol Ther, 2006, 23 (11): 1567-1574.
14. Miele E, Pascarella F, Giannetti E, et al. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis[J]. Am J Gastroenterol, 2009, 104 (2): 437-443.
15. Sood A, Midha V, Makharia G K, et al. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis[J]. Clin Gastroenterol Hepatol, 2009, 7 (11): 1202-1209.
16. Tursi A, Brandimarte G, Papa A, et al. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study[J]. Am J Gastroenterol, 2010, 105 (10): 2218-2227.
17. Wildt S, Nordgaard I, Hansen U, et al. A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis[J]. J Crohns Colitis, 2011, 5 (2): 115-121.
18. Federico A, Tuccillo C, Grossi E, et al. The effect of a new symbiotic formulation on plasma levels and peripheral blood mononuclear cell expression of some pro-inflammatory cytokines in patients with ulcerative colitis: a pilot study[J]. Eur Rev Med Pharmacol Sci, 2009, 13 (4): 285-293.
19. Kruis W, Schütz E, Fric P, et al. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis [J]. Aliment Pharmacol Ther, 1997, 11 (5): 853-858.
20. Mallon P, McKay D, Kirk S, et al. Probiotics for induction of remission in ulcerative colitis [J]. Cochrane Database Syst Rev, 2007 (4): CD005573.
21. 2008, 8 (5): 315-321.
22. Turner D, Otley A R, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study[J]. Gastroenterology, 2007, 133 (2): 423-432.